Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Saturday, July 2, 2022 · 579,490,653 Articles · 3+ Million Readers

Statement from HHS Secretary Xavier Becerra on FDA and CDC Expanding Eligibility for Pfizer-BioNTech COVID-19 Vaccine Boosters for 5-11 Year Olds

Following action taken earlier this week by U.S. Food and Drug Administration (FDA) and today by the Centers for Disease Control and Prevention (CDC) to expand eligibility for a booster shot of the Pfizer-BioNTech COVID-19 Vaccine to children 5 through 11, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra issued the following statement:

“We are focused on making sure Americans have access to COVID-19 vaccines and boosters, which are very best tools to prevent severe disease and save lives. Thanks to the FDA and CDC’s rigorous, comprehensive, and independent review of the data and their strict commitment to following the science, children 5 through 11 are now eligible for a booster shot of the Pfizer-BioNTech COVID-19 Vaccine.

“Nearly 102 million Americans have already received a booster shot, but too many people haven’t yet stepped up to get their booster shot. As FDA and CDC have made clear, getting a booster is incredibly important, including for children 5 through 11. If you are vaccinated and boosted, your odds of getting severely ill, going to the hospital, or dying are dramatically lower. People can go to to find free and easily available vaccines in their community. If we all do our part, we can continue to be safe, stay protected, and move forward together.”

Powered by EIN Presswire
Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release